Trials / Completed
CompletedNCT03006640
Subcutaneous NTG for US Radial Artery Cannulation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- AlRefaey Kandeel · Academic / Other
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Clinicians are increasingly dealing with morbid obese patients. In morbid obese patients, difficult sampling and problems encountered with noninvasive blood pressure monitoring makes arterial cannulation an essential skill in many situations like surgeries or trans-radial procedures for coronary or carotid interventions. Radial artery has been preferred over other sites for arterial cannulation due to low incidence of bleeding, better hemostats, more comfort, and immediate ambulation. sm In this study, subcutaneous nitroglycerin will be used to facilitate radial artery cannulation aiming to decrease insertion time, increase success rate and decrease related complications
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Subcutaneous nitroglycrin | In both groups, a 1 ml filled insulin syringe is delivered to a blinded operator who infiltrated it subcutaneously over 1 cm along the radial artery course. In the NTG group, the syringe contains 200 µg of NTG while in control group the syringe is filled with saline |
| DRUG | Subcutaneous saline | In both groups, a 1 ml filled insulin syringe is delivered to a blinded operator who infiltrated it subcutaneously over 1 cm along the radial artery course. In the NTG group, the syringe contains 200 µg of NTG while in control group the syringe is filled with saline |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-06-01
- Completion
- 2016-11-01
- First posted
- 2016-12-30
- Last updated
- 2016-12-30
Source: ClinicalTrials.gov record NCT03006640. Inclusion in this directory is not an endorsement.